Literature DB >> 7144919

Early and specific detection of frequently occurring human carcinomata.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7144919

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN： 0028-1042


× No keyword cloud information.
  11 in total

Review 1.  Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them.

Authors:  G F Springer; P R Desai; M S Murthy; H Tegtmeyer; E F Scanlon
Journal:  Prog Allergy       Date:  1979

2.  Blood group MN specific substances and precursors in normal and malignant human breast tissues.

Authors:  G F Springer; P R Desai; I Banatwala
Journal:  Naturwissenschaften       Date:  1974-10

3.  Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.

Authors:  G F Springer; S M Murthy; P R Desai; W A Fry; H Tegtmeyer; E F Scanlon
Journal:  Klin Wochenschr       Date:  1982-02-01

4.  The Thomsen agglutination phenomenon: a discovery revisited 50 years later.

Authors:  P Vaith; G Uhlenbruck
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978

5.  Detection of lung- and breast carcinoma by quantitating serum anti-T IgM levels with a sensitive, solid-phase immunoassay.

Authors:  G F Springer; P R Desai
Journal:  Naturwissenschaften       Date:  1982-07

6.  The rate of growth and natural duration of primary bronchial cancer.

Authors:  L H Garland
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1966-03

7.  Antibody responses to T-activated red cells in children from high- and low-risk areas of cancer of the oesophagus in Transkei.

Authors:  G H Vos; E F Rose; D Vos
Journal:  S Afr Med J       Date:  1981-07-11

8.  Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them.

Authors:  G F Springer; P R Desai; E F Scanlon
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

9.  Anti-T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy--changes in serum levels following C parvum, BCG immunization.

Authors:  N Thatcher; K Hashmi; J Chang; R Swindell; D Crowther
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

10.  Heterophile antibodies, immunoglobulin levels, and the evaluation on anti-T activity in cancer patients and controls.

Authors:  G H Vos; P Brain
Journal:  S Afr Med J       Date:  1981-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.